U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.


Dan Bongino to Step Down as FBI Deputy Director After Brief, Controversial Tenure
Trump Announces $1,776 Cash Bonus for U.S. Military Personnel Ahead of Christmas
Venezuela Seeks UN Security Council Meeting Over U.S. Oil Tanker Blockade
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Neuralink Expands Brain Implant Trials with 12 Global Patients
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Honduras Election Recount Delayed Amid Protests and Political Tensions
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Lab-grown meat: you may find it icky, but it could drive forward medical research
Zelenskiy Urges Allies to Use Frozen Russian Assets as EU Summit Nears
Tabletop particle accelerator could transform medicine and materials science
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 



